The Chinese non-small-cell lung cancer (NSCLC) drug market is expected to more than double by 2013
2009 ◽
Vol 579
(1)
◽
pp. 15-15
Keyword(s):
2009 ◽
Vol 576
(1)
◽
pp. 15-15
Keyword(s):
2016 ◽
Vol 15
(4)
◽
pp. 229-230
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):